Lowe Wealth Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.67K | Hold |
50
| – | – | ﹤0.01% | 264 |
|
|
2025
Q2 | $6.99K | Hold |
50
| – | – | ﹤0.01% | 268 |
|
|
2025
Q1 | $7.35K | Hold |
50
| – | – | ﹤0.01% | 264 |
|
|
2024
Q4 | $6.55K | Hold |
50
| – | – | ﹤0.01% | 255 |
|
|
2024
Q3 | $7.79K | Hold |
50
| – | – | ﹤0.01% | 235 |
|
|
2024
Q2 | $7.8K | Hold |
50
| – | – | ﹤0.01% | 233 |
|
|
2024
Q1 | $6.78K | Hold |
50
| – | – | ﹤0.01% | 232 |
|
|
2023
Q4 | $6.74K | Hold |
50
| – | – | ﹤0.01% | 231 |
|
|
2023
Q3 | $6.77K | Hold |
50
| – | – | ﹤0.01% | 223 |
|
|
2023
Q2 | $7.16K | Hold |
50
| – | – | ﹤0.01% | 245 |
|
|
2023
Q1 | $6.94K | Hold |
50
| – | – | ﹤0.01% | 239 |
|
|
2022
Q4 | $6.78K | Hold |
50
| – | – | ﹤0.01% | 239 |
|
|
2022
Q3 | $5K | Hold |
50
| – | – | ﹤0.01% | 235 |
|
|
2022
Q2 | $7K | Hold |
50
| – | – | ﹤0.01% | 208 |
|
|
2022
Q1 | $7K | Hold |
50
| – | – | ﹤0.01% | 220 |
|
|
2021
Q4 | $6K | Hold |
50
| – | – | ﹤0.01% | 214 |
|
|
2021
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 210 |
|
|
2021
Q2 | $6K | Hold |
50
| – | – | ﹤0.01% | 203 |
|
|
2021
Q1 | $5K | Hold |
50
| – | – | ﹤0.01% | 203 |
|
|
2020
Q4 | $5K | Hold |
50
| – | – | ﹤0.01% | 202 |
|
|
2020
Q3 | $5K | Hold |
50
| – | – | ﹤0.01% | 190 |
|
|
2020
Q2 | $5K | Hold |
50
| – | – | ﹤0.01% | 183 |
|
|
2020
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 195 |
|
|
2019
Q4 | $5K | Hold |
50
| – | – | ﹤0.01% | 198 |
|
|
2019
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 198 |
|
|
2019
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 211 |
|
|
2019
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 183 |
|
|
2018
Q4 | $4K | Hold |
50
| – | – | ﹤0.01% | 172 |
|
|
2018
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 193 |
|
|
2018
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 173 |
|
|
2018
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 188 |
|
|
2017
Q4 | $3K | Hold |
50
| – | – | ﹤0.01% | 199 |
|
|
2017
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 199 |
|
|
2017
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 174 |
|
|
2017
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 172 |
|
|
2016
Q4 | $3K | Hold |
50
| – | – | ﹤0.01% | 177 |
|
|
2016
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 180 |
|
|
2016
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 172 |
|
|
2016
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 165 |
|
|
2015
Q4 | $3K | Hold |
50
| – | – | ﹤0.01% | 177 |
|
|
2015
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 173 |
|
|
2015
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 173 |
|
|
2015
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 177 |
|
|
2014
Q4 | $4K | Buy |
+50
| New | +$3.58K | ﹤0.01% | 148 |
|
Other funds holding AZN
Lowe Wealth Advisors's AZN Position: Q3 2025 in Review
Lowe Wealth Advisors held its AstraZeneca (AZN) position steady in Q3 2025 at 50 shares worth $7.67K. The position accounts for ﹤0.01% of the portfolio, ranked #264.
Lowe Wealth Advisors first reported a position in AZN in Q4 2014 and has held it in 44 quarters since. The position peaked at $7.8K in Q2 2024. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.
- Lowe Wealth Advisors held 50 shares of AstraZeneca worth $7.67K as of Q3 2025.
- Lowe Wealth Advisors left its AstraZeneca share count unchanged in Q3 2025.
- AstraZeneca made up ﹤0.01% of Lowe Wealth Advisors's portfolio in Q3 2025, its #264 holding.
- Lowe Wealth Advisors first reported a position in AstraZeneca in Q4 2014 and has held it in 44 quarters since.
- Lowe Wealth Advisors's AstraZeneca position peaked at $7.8K in Q2 2024.
- 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.
Based on Lowe Wealth Advisors's 13F filing for Q3 2025, filed 16 Oct 2025.